RPS4Y2
gene geneOn this page
Summary
RPS4Y2 (ribosomal protein S4 Y-linked 2, HGNC:18501) is a protein-coding gene on chromosome Yq11.223, encoding Small ribosomal subunit protein eS4, Y isoform 2 (Q8TD47).
The protein encoded by this gene is a ribosomal protein that is highly similar to RPS4Y1. This gene is located in the male-specific region of the Y chromosome.
Source: NCBI Gene 140032 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 4 total
- Phenotypes (HPO): 4
- MANE Select transcript:
NM_001039567
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18501 |
| Approved symbol | RPS4Y2 |
| Name | ribosomal protein S4 Y-linked 2 |
| Location | Yq11.223 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000280969 |
| Ensembl biotype | protein_coding |
| OMIM | 400030 |
| Entrez | 140032 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000629237
RefSeq mRNA: 1 — MANE Select: NM_001039567
NM_001039567
CCDS: CCDS44028
Canonical transcript exons
ENST00000629237 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003760466 | 20761284 | 20761381 |
| ENSE00003766131 | 20756778 | 20756855 |
| ENSE00003769571 | 20780931 | 20781032 |
| ENSE00003771585 | 20759868 | 20760048 |
| ENSE00003772521 | 20779509 | 20779666 |
| ENSE00003772865 | 20768805 | 20768976 |
| ENSE00003773208 | 20756108 | 20756166 |
Expression profiles
Bgee: expression breadth broad, 20 present calls, max score 83.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0476 / max 59.7660, expressed in 2 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201203 | 0.0334 | 2 |
| 201202 | 0.0142 | 1 |
Top tissues by expression
84 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.89 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.20 | gold quality |
| right testis | UBERON:0004534 | 51.98 | gold quality |
| testis | UBERON:0000473 | 51.25 | gold quality |
| left testis | UBERON:0004533 | 49.57 | gold quality |
| prostate gland | UBERON:0002367 | 48.86 | gold quality |
| bone marrow cell | CL:0002092 | 43.90 | gold quality |
| ganglionic eminence | UBERON:0004023 | 41.80 | gold quality |
| bone marrow | UBERON:0002371 | 41.73 | silver quality |
| ventricular zone | UBERON:0003053 | 40.82 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 37.20 | silver quality |
| blood | UBERON:0000178 | 36.52 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.11 | gold quality |
| rectum | UBERON:0001052 | 35.60 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 35.03 | gold quality |
| spleen | UBERON:0002106 | 34.36 | silver quality |
| tonsil | UBERON:0002372 | 34.23 | gold quality |
| right lung | UBERON:0002167 | 33.61 | gold quality |
| muscle tissue | UBERON:0002385 | 32.27 | gold quality |
| primary visual cortex | UBERON:0002436 | 31.36 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| small intestine | UBERON:0002108 | 30.82 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 30.50 | gold quality |
| vermiform appendix | UBERON:0001154 | 29.96 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| hypothalamus | UBERON:0001898 | 29.49 | silver quality |
| placenta | UBERON:0001987 | 28.48 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.41 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- One of the Y-linked copies of the ribosomal protein S4 is expressed during spermatogenesis and germ cell development and the C-terminus of the protein has some degree of functional specialisation of this protein in spermatogenesis. (PMID:20459660)
- LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2. (PMID:32494880)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rps4x | ENSDARG00000014690 |
| drosophila_melanogaster | RpS4 | FBGN0011284 |
| caenorhabditis_elegans | WBGENE00004473 |
Paralogs (2): RPS4Y1 (ENSG00000129824), RPS4X (ENSG00000198034)
Protein
Protein identifiers
Small ribosomal subunit protein eS4, Y isoform 2 — Q8TD47 (reviewed: Q8TD47)
Alternative names: 40S ribosomal protein S4, Y isoform 2
All UniProt accessions (1): Q8TD47
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the eukaryotic ribosomal protein eS4 family.
RefSeq proteins (1): NP_001034656* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000876 | Ribosomal_eS4 | Family |
| IPR005824 | KOW | Domain |
| IPR013843 | Ribosomal_eS4_N | Domain |
| IPR013845 | Ribosomal_eS4_central_region | Domain |
| IPR014722 | Rib_uL2_dom2 | Homologous_superfamily |
| IPR018199 | Ribosomal_eS4_N_CS | Conserved_site |
| IPR032277 | Ribosomal_eS4_C | Domain |
| IPR036986 | S4_RNA-bd_sf | Homologous_superfamily |
| IPR038237 | Ribosomal_eS4_central_sf | Homologous_superfamily |
| IPR041982 | Ribosomal_eS4_KOW | Domain |
Pfam: PF00467, PF00900, PF08071, PF16121
UniProt features (2 total): chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TD47-F1 | 95.62 | 0.98 |
Function
Pathways and Gene Ontology
Reactome pathways
50 pathways
| ID | Pathway |
|---|---|
| R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression |
| R-HSA-156902 | Peptide chain elongation |
| R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane |
| R-HSA-192823 | Viral mRNA Translation |
| R-HSA-2408557 | Selenocysteine synthesis |
| R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol |
| R-HSA-72649 | Translation initiation complex formation |
| R-HSA-72689 | Formation of a pool of free 40S subunits |
| R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex |
| R-HSA-72702 | Ribosomal scanning and start codon recognition |
| R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit |
| R-HSA-72764 | Eukaryotic Translation Termination |
| R-HSA-9010553 | Regulation of expression of SLITs and ROBOs |
| R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency |
| R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery |
| R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery |
| R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
| R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
| R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA |
| R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-1430728 | Metabolism |
| R-HSA-156842 | Eukaryotic Translation Elongation |
| R-HSA-1643685 | Disease |
| R-HSA-168255 | Influenza Infection |
| R-HSA-168273 | Influenza Viral RNA Transcription and Replication |
| R-HSA-2262752 | Cellular responses to stress |
| R-HSA-2408522 | Selenoamino acid metabolism |
| R-HSA-376176 | Signaling by ROBO receptors |
| R-HSA-392499 | Metabolism of proteins |
MSigDB gene sets: 62 (showing top):
GOBP_TRANSLATION, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, REACTOME_METABOLISM_OF_RNA, GOCC_RIBOSOME, GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOMAL_SUBUNIT, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOCC_CYTOSOLIC_RIBOSOME, GOMF_RRNA_BINDING, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, chrYq11, REACTOME_SELENOAMINO_ACID_METABOLISM, REACTOME_INFECTIOUS_DISEASE, REACTOME_RRNA_PROCESSING
GO Biological Process (1): translation (GO:0006412)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), rRNA binding (GO:0019843)
GO Cellular Component (3): cytosolic small ribosomal subunit (GO:0022627), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-14 pathways:
| Category | Pathways |
|---|---|
| Cap-dependent Translation Initiation | 4 |
| Translation | 2 |
| Nonsense-Mediated Decay (NMD) | 2 |
| Ribosome-associated quality control | 2 |
| Eukaryotic Translation Initiation | 1 |
| Eukaryotic Translation Elongation | 1 |
| Influenza Viral RNA Transcription and Replication | 1 |
| Selenoamino acid metabolism | 1 |
| rRNA processing in the nucleus and cytosol | 1 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 1 |
| Signaling by ROBO receptors | 1 |
| Cellular response to starvation | 1 |
| SARS-CoV-1-host interactions | 1 |
| SARS-CoV-2-host interactions | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| RNA binding | 1 |
| small ribosomal subunit | 1 |
| cytosolic ribosome | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1893 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RPS4Y2 | EIF1AY | O14602 | 750 |
| RPS4Y2 | RPL39L | Q96EH5 | 648 |
| RPS4Y2 | HSFY1 | Q96LI6 | 634 |
| RPS4Y2 | KDM5D | Q9BY66 | 630 |
| RPS4Y2 | USP9Y | O00507 | 607 |
| RPS4Y2 | RBMY1A1 | P0DJD3 | 602 |
| RPS4Y2 | RPL10L | Q96L21 | 597 |
| RPS4Y2 | PRKY | O43930 | 585 |
| RPS4Y2 | DDX3Y | O15523 | 584 |
| RPS4Y2 | CDY2A | Q9Y6F7 | 577 |
| RPS4Y2 | ZFY | P08048 | 575 |
| RPS4Y2 | BPY2 | O14599 | 571 |
| RPS4Y2 | TMSB4Y | O14604 | 555 |
| RPS4Y2 | A6NEC3 | A6NEC3 | 546 |
| RPS4Y2 | VCY | O14598 | 544 |
| RPS4Y2 | PRY | O14603 | 544 |
IntAct
57 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| LRRC46 | TBP | psi-mi:“MI:0914”(association) | 0.640 |
| CSNK1E | POTEF | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| EMILIN1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | MYO9A | psi-mi:“MI:0914”(association) | 0.530 |
| RPS2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| KRR1 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF428 | S100A10 | psi-mi:“MI:0914”(association) | 0.530 |
| SDC1 | ILVBL | psi-mi:“MI:0915”(physical association) | 0.400 |
| ITM2B | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| rl36a_rl36l_human | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
| rl3_rl3l_human | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPS4Y1 | CCT3 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| RPLP0 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RBM4B | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL4 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| SURF6 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL7A | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF668 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| PRKRA | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| NEIL1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF346 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| MBNL1 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| RPS6 | psi-mi:“MI:0914”(association) | 0.350 | |
| RPS8 | psi-mi:“MI:0914”(association) | 0.350 | |
| DAXX | psi-mi:“MI:0914”(association) | 0.350 | |
| H1-1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (83): RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Proximity Label-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS), RPS4Y2 (Affinity Capture-MS)
ESM2 similar proteins: A0A1D8PCI6, A4FWA9, A6VGZ7, G1TK17, O22424, O59950, O62738, O62739, P0CX35, P0CX36, P22090, P41042, P46299, P46300, P47836, P47837, P47961, P49204, P49398, P49401, P51405, P62701, P62702, P62703, P62704, P62705, P79103, P79183, P87158, Q0W1X6, Q4GXU6, Q4PMB3, Q56FH2, Q5UAP0, Q642H9, Q6GVM7, Q6PBC4, Q76MY1, Q76N24, Q861U7
Diamond homologs: A0A1D8PCI6, A1RS06, A2BMD1, A3DNB9, A3MWZ7, A4FWA9, A4WLL4, A4YCX8, A5UL76, A6UQ56, A6UWV0, A6VGZ7, A8ACD4, A8MB20, A9A9Q2, B1L778, B1Y9S4, B8D5V8, C3MQ71, C3MVJ0, C3N5T9, C3NEF5, C3NH97, C4KHG8, G1TK17, O05634, O22424, O26123, O28366, O59430, O59950, O62738, O62739, O81363, P0C233, P0CX35, P0CX36, P14023, P22090, P41042
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| RPS4Y2 | “form complex” | “40S cytosolic small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 80 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Eukaryotic Translation Initiation | 9 | 50.5× | 1e-12 |
| Cap-dependent Translation Initiation | 9 | 50.5× | 1e-12 |
| SARS-CoV-1 modulates host translation machinery | 9 | 50.5× | 1e-12 |
| Eukaryotic Translation Elongation | 9 | 45.6× | 3e-12 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 9 | 44.5× | 3e-12 |
| Influenza Viral RNA Transcription and Replication | 10 | 39.2× | 7e-13 |
| Nonsense-Mediated Decay (NMD) | 9 | 38.1× | 1e-11 |
| SARS-CoV-2 modulates host translation machinery | 9 | 36.6× | 2e-11 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 15 | 38.6× | 8e-18 |
| ribosomal small subunit biogenesis | 8 | 25.3× | 1e-07 |
| translation | 16 | 22.8× | 1e-15 |
| rRNA processing | 6 | 11.8× | 7e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1511 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| Y:20756852:ATTT:A | donor_gain | 1.0000 |
| Y:20756853:TTT:T | donor_gain | 1.0000 |
| Y:20756854:TT:T | donor_gain | 1.0000 |
| Y:20756856:G:GG | donor_gain | 1.0000 |
| Y:20756856:GTGA:G | donor_loss | 1.0000 |
| Y:20756857:TGAG:T | donor_loss | 1.0000 |
| Y:20756858:G:GT | donor_loss | 1.0000 |
| Y:20756859:AG:A | donor_loss | 1.0000 |
| Y:20768803:A:AG | acceptor_gain | 1.0000 |
| Y:20768804:G:GG | acceptor_gain | 1.0000 |
| Y:20779503:CTCTA:C | acceptor_loss | 1.0000 |
| Y:20779504:TCTAG:T | acceptor_loss | 1.0000 |
| Y:20779505:CTA:C | acceptor_loss | 1.0000 |
| Y:20779506:TAG:T | acceptor_loss | 1.0000 |
| Y:20779507:A:AG | acceptor_gain | 1.0000 |
| Y:20779507:AG:A | acceptor_gain | 1.0000 |
| Y:20779507:AGGCA:A | acceptor_loss | 1.0000 |
| Y:20779508:G:GG | acceptor_gain | 1.0000 |
| Y:20779508:G:T | acceptor_loss | 1.0000 |
| Y:20779508:GG:G | acceptor_gain | 1.0000 |
| Y:20779508:GGC:G | acceptor_gain | 1.0000 |
| Y:20779508:GGCA:G | acceptor_gain | 1.0000 |
| Y:20779662:GCAAT:G | donor_gain | 1.0000 |
| Y:20779667:G:GG | donor_gain | 1.0000 |
| Y:20756410:GAA:G | donor_gain | 0.9900 |
| Y:20756562:GACTC:G | donor_gain | 0.9900 |
| Y:20756772:TTTCA:T | acceptor_loss | 0.9900 |
| Y:20756773:TTCAG:T | acceptor_loss | 0.9900 |
| Y:20756774:TCA:T | acceptor_loss | 0.9900 |
| Y:20756775:CAGGC:C | acceptor_loss | 0.9900 |
AlphaMissense
1733 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:20756853:T:C | F27L | 0.958 |
| Y:20756855:T:A | F27L | 0.958 |
| Y:20756855:T:G | F27L | 0.958 |
| Y:20779628:T:C | F218L | 0.951 |
| Y:20779630:T:A | F218L | 0.951 |
| Y:20779630:T:G | F218L | 0.951 |
| Y:20761316:T:C | F99L | 0.894 |
| Y:20761318:C:A | F99L | 0.894 |
| Y:20761318:C:G | F99L | 0.894 |
| Y:20761346:T:C | F109L | 0.881 |
| Y:20761348:T:A | F109L | 0.881 |
| Y:20761348:T:G | F109L | 0.881 |
| Y:20768967:T:C | F175L | 0.844 |
| Y:20768969:T:A | F175L | 0.844 |
| Y:20768969:T:G | F175L | 0.844 |
| Y:20779652:T:C | F226L | 0.841 |
| Y:20779654:T:A | F226L | 0.841 |
| Y:20779654:T:G | F226L | 0.841 |
| Y:20779599:T:A | V208E | 0.831 |
| Y:20756804:G:C | K10N | 0.817 |
| Y:20756804:G:T | K10N | 0.817 |
| Y:20768958:T:C | F172L | 0.817 |
| Y:20768960:T:A | F172L | 0.817 |
| Y:20768960:T:G | F172L | 0.817 |
| Y:20756826:T:A | W18R | 0.814 |
| Y:20756826:T:C | W18R | 0.814 |
| Y:20768923:T:A | V160E | 0.796 |
| Y:20759933:G:C | R49S | 0.784 |
| Y:20759933:G:T | R49S | 0.784 |
| Y:20768810:G:C | K122N | 0.776 |
dbSNP variants (sampled 300 via entrez): RS1000117736 (Y:20772154 G>C), RS1000170809 (Y:20773684 G>A), RS1000482247 (Y:20763878 G>A), RS1002153232 (Y:20756795 G>A), RS1002516877 (Y:20765914 G>T), RS1004330880 (Y:20758245 G>A), RS1004620593 (Y:20759976 A>T), RS1006358354 (Y:20777606 G>A), RS1006406358 (Y:20778686 C>T), RS1006718065 (Y:20770476 T>C), RS1007140544 (Y:20771779 T>A), RS1008398896 (Y:20763352 G>T), RS1008722721 (Y:20755276 A>G), RS1009147505 (Y:20756647 G>A), RS1009364430 (Y:20760885 T>G)
Disease associations
OMIM: gene MIM:400030 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
4 total (4 of 4 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000027 | Azoospermia |
| HP:0001450 | Y-linked inheritance |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | increases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| MRK 003 | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Vanadates | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.